Nissui Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Nissui Pharmaceutical Co. Ltd.
DFA International Small Cap Value Portfolio
147,100
0.65%
22,400
0.01%
04/30/2018
Nomura Asset TOPIX ETF Fund (1306)
132,600
0.59%
2,100
0%
07/31/2018
DFA Japanese Small Company Series
77,300
0.34%
2,400
0.02%
01/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
65,100
0.28%
-1,900
0%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
60,000
0.27%
0
0%
08/20/2018
DFA International Core Equity Portfolio
49,900
0.22%
-3,500
0%
04/30/2018
Russell Smaller Companies Pool
25,800
0.11%
13,800
0.16%
12/31/2017
Russell Invt. Co. Plc - Acadian Global Managed Volatility Eq.
25,300
0.11%
20,200
0.02%
09/30/2017
Mitsubishi UFJ MAXIS TOPIX ETF (1348)
17,400
0.08%
500
0%
07/31/2018
DFA International Vector Equity Portfolio
10,000
0.04%
0
0%
04/30/2018
| Address |
Nissuiseiyaku Building
Tokyo Tokyo 110
Japan
|
|
Employees
|
- |
| Website |
http://www.nissui-pharm.co.jp |
| Updated |
07/08/2019 |
| Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostics for medical institutions, research organizations, and food industries. Its operations are carried out through the following segments: Clinical Diagnostics and Pharmaceuticals. The Clinical Diagnostics segment provides reagents and instruments for microbiological and immunological tests, and also quality control materials for human diagnostic use, food sanitation use and biological research in both the public and private organizations. |
